This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 May 2014

Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG

Cenix BioScience GmbH, a leading preclinical contract research provider and technology developer specialized in RNAi-based genomics and high content screening-driven pharmacology, has signed a research service agreement with Bayer Pharma AG (Bayer).


Under the agreement, Cenix will undertake a target discovery project for an undisclosed disease indication by applying its longstanding industry-leading expertise in high throughput RNAi for genome-scale screening in advanced cell models.


Financial terms were not disclosed.

Related News